Analyst consensus rating
Inspire Medical Systems Analyst Rating: none
INSP is rated none by 15 analysts with a $60.40 target. As of 2026-09-01.
Direct answer
Inspire Medical Systems's consensus rating is none.
15 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $60.40.
Forecast evidence checked September 1, 2026.
Get free Inspire Medical Systems email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $62.99
- Average price target
- $60.40
- High price target
- $85.00
- Low price target
- $40.00
- Low target gap
- -36.5%
- Target upside
- -4.1%
- High target gap
- +34.9%
- Target range width
- 71.4%
- Consensus rating
- none
- Analysts
- 15
- Evidence date
- September 1, 2026
- Valid through
- September 8, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Inspire Medical Systems?
Inspire Medical Systems has a verified none consensus. The same dataset has an average price target of $60.40.
How far are Inspire Medical Systems's low and high targets from the recorded price?
The low target implies -36.5%, while the high target implies +34.9%.
How many analysts are included in Inspire Medical Systems's consensus?
The verified consensus includes 15 analysts.
How is Inspire Medical Systems's target upside or downside calculated?
The average target of $60.40 is divided by the recorded price of $62.99, then one is subtracted to produce -4.1%. This does not guarantee a future return.
When was Inspire Medical Systems's analyst forecast verified?
The data was verified on 2026-09-01. The dataset is valid through 2026-09-08.